Expectations trend
FY2028 · fiscal year ending 2028-04-30 · fmp
MAISON SOLUTIONS INC (MSS)
NASDAQConsumer StaplesGrocery StoresSnapshot 2026-11-04
$0.98-16.15%
Close 2026-11-05 · 1-day change
NASDAQConsumer StaplesGrocery StoresSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.29 → 1.29 EPS · FY ending Apr 30, 2028 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for MSS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Complete sale of non-core assets | Maison Solutions is working to fix its problems by selling non-core assets. | Improving | Disposition not completed by mid-2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-04-30 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative, high-risk situation rather than a proven durable compounder, with weak recent results and volatile management execution. The long-term thesis is in a watch state: the signal recently shifted from cautious to mixed, but the business has not shown a fresh recovery.
The evidence points to MSS being cheap versus peers, while the expectations gap is negative; the valuation model has low confidence. The market appears to allow for some weakness, but the evidence does not show that the risks of continued losses, erratic results, or regulatory trouble are fully reflected.
Near term, erratic earnings and a higher-than-usual risk of missing expectations make results difficult to rely on. Management is pursuing asset sales, acquisitions, and capital-allocation changes, but these efforts remain mixed, and the company was still delinquent on required filings as of the latest quarter. A softer jobs trend could add pressure, while strength among sector peers may support the broader sector backdrop.
The multi-year thesis hinges on management regaining and maintaining Nasdaq listing compliance, improving financial performance, and showing that portfolio and capital-allocation actions help the business. Near term, a weaker jobs trend and disappointing results from sector bellwethers could weaken the sector tailwind; continued strong results from those peers could sustain it.
Over the next 1 to 3 years, MSS remains a fragile, loss-making case with a potentially supportive sector backdrop but substantial execution and regulatory risks. The key evidence to watch is compliance progress and whether financial performance improves. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in MAISON SOLUTIONS INC's published investment case. The stated target is EPS >= $0.5 in FY27. |
| Intact |
| EPS falls below $0.5 in FY27 |
Diluted EPS: $-0.21 per share FY2026-Q3; GAAP. Published target: EPS >= $0.5 in FY27. Annual target cannot be compared with a quarterly or TTM observation. Mar 17, 2026-0.21 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stabilize management and governance | It aims to resolve Nasdaq compliance issues and improve management stability. | Under Pressure | Continued high management volatility into FY27 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Resolve Nasdaq non-compliance issue | It aims to resolve Nasdaq compliance issues and improve management stability. | Under Pressure | Nasdaq non-compliance persists beyond FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.26 → $1.29 · observed estimates
$0.09B → $0.09B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.26 | $89,581,000 | 1 / 1 |
| 2026-07-25 | $0.26 | $89,581,000 | 1 / 1 |
| 2026-07-26 | $0.26 | $89,581,000 | 1 / 1 |
| 2026-07-27 | $1.30 | $89,581,000 | 1 / 1 |
| 2026-07-28 | $1.30 | $89,581,000 | 1 / 1 |
| 2026-07-29 | $1.30 | $89,581,000 | 1 / 1 |
| 2026-07-30 | $1.30 | $89,581,000 | 1 / 1 |
| 2026-07-31 | $1.30 | $89,581,000 | 1 / 1 |
| 2026-08-01 | $1.30 | $89,581,000 | 1 / 1 |
| 2026-08-02 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-03 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-04 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-05 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-06 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-07 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-08 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-09 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-10 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-12 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-13 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-14 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-15 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-16 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-17 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-18 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-19 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-20 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-21 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-22 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-23 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-24 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-25 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-26 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-27 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-28 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-29 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-30 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-08-31 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-01 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-02 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-03 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-04 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-05 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-06 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-07 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-08 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-09 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-10 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-11 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-12 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-13 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-14 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-15 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-16 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-17 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-18 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-19 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-20 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-21 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-22 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-23 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-24 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-25 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-26 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-27 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-28 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-29 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-09-30 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-01 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-02 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-03 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-04 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-05 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-06 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-07 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-08 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-09 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-10 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-11 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-12 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-13 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-14 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-15 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-16 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-17 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-18 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-19 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-20 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-21 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-22 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-23 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-24 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-25 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-26 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-27 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-28 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-29 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-30 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-10-31 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-11-01 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-11-02 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-11-03 | $1.29 | $89,581,000 | 1 / 1 |
| 2026-11-04 | $1.29 | $89,581,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 0 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Dec 28, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.